Australia is closely watching the arrival of retatrutide, a novel dual GIP and GLP-1 receptor therapy, representing a significant advance in weight loss . Early clinical trials have demonstrated impressive https://anyaodoa175737.tinyblogging.com/retatrutide-in-australia-a-potential-hope-for-reducing-body-weight-88103290